This company has been marked as potentially delisted and may not be actively trading. Osmotica Pharmaceuticals (OSMT) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Osmotica Pharmaceuticals Short Interest DataOsmotica Pharmaceuticals (OSMT) has a short interest of 412,200 shares, representing 1.02% of the float (the number of shares available for trading by the public). This marks a 263.49% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 396,682 shares to cover all short positions.Current Short Interest412,200 sharesPrevious Short Interest113,400 sharesChange Vs. Previous Month+263.49%Dollar Volume Sold Short$445.18 thousandShort Interest Ratio0.6 Days to CoverLast Record DateDecember 31, 2021Outstanding Shares62,585,000 sharesFloat Size40,400,000 sharesShort Percent of Float1.02%Today's Trading Volume296,500 sharesAverage Trading Volume396,682 sharesToday's Volume Vs. Average75% Short Selling Osmotica Pharmaceuticals? Sign up to receive the latest short interest report for Osmotica Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOSMT Short Interest Over TimeOSMT Days to Cover Over TimeOSMT Percentage of Float Shorted Over Time Osmotica Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2021412,200 shares $445.18 thousand +263.5%1.0%0.6 $1.08 12/15/2021113,400 shares $120.20 thousand -12.8%0.3%0.1 $1.06 11/30/2021130,000 shares $172.90 thousand -46.8%0.3%0.2 $1.33 11/15/2021244,400 shares $476.58 thousand -11.1%0.6%0.3 $1.95 10/29/2021274,900 shares $489.32 thousand +343.4%1.0%0.4 $1.78 10/15/202162,000 shares $120.28 thousand -89.0%0.3%0.1 $1.94 9/30/2021562,900 shares $1.66 million +1.0%2.8%1 $2.95 9/15/2021557,500 shares $1.65 million -7.7%2.8%0.4 $2.96 8/31/2021603,800 shares $2.13 million -58.1%3.0%0.5 $3.52 8/13/20211,440,000 shares $5.99 million -8.9%7.3%1.1 $4.16 Get the Latest News and Ratings for OSMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Osmotica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/30/20211,580,000 shares $5.26 million -21.0%8.0%1.2 $3.33 7/15/20212,000,000 shares $6.50 million -13.4%10.1%1.5 $3.25 6/30/20212,310,000 shares $6.95 million -10.1%11.7%1.8 $3.01 6/15/20212,570,000 shares $7.74 million -1.2%12.9%10.1 $3.01 5/28/20212,600,000 shares $7.57 million -7.5%13.1%9.9 $2.91 5/14/20212,810,000 shares $8.63 million +2.6%14.1%10 $3.07 4/30/20212,740,000 shares $8.14 million +10.0%13.6%8.6 $2.97 4/15/20212,490,000 shares $7.57 million +5.1%17.2%7.4 $3.04 3/31/20212,370,000 shares $8.32 million +12.3%16.4%6.5 $3.51 3/15/20212,110,000 shares $7.79 million +14.1%14.6%4.1 $3.69 2/26/20211,850,000 shares $7.33 million -8.9%12.8%3.7 $3.96 2/12/20212,030,000 shares $9.20 million -7.7%14.1%4.1 $4.53 1/29/20212,200,000 shares $9.31 million +2.3%15.2%4.6 $4.23 1/15/20212,150,000 shares $9.68 million +74.8%14.9%4.7 $4.50 12/31/20201,230,000 shares $5.20 million +4.2%8.5%2.8 $4.23 12/15/20201,180,000 shares $7.09 million -3.3%8.2%4.2 $6.01 11/30/20201,220,000 shares $7.47 million -0.8%8.4%4.3 $6.12 11/15/20201,230,000 shares $7.24 million -1.6%8.0%4.1 $5.89 10/30/20201,250,000 shares $6.73 million +6.8%8.0%4 $5.38 10/15/20201,170,000 shares $6.82 million -40.3%7.5%3.3 $5.83 9/30/20201,960,000 shares $10.60 million +12.6%12.5%3.6 $5.41 9/15/20201,740,000 shares $8.40 million +127.2%11.1%3 $4.83 8/31/2020765,900 shares $4.55 million -13.0%4.9%1.3 $5.94 OSMT Short Interest - Frequently Asked Questions What is Osmotica Pharmaceuticals' current short interest? Short interest is the volume of Osmotica Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 412,200 shares of OSMT short. 1.02% of Osmotica Pharmaceuticals' shares are currently sold short. Learn More on Osmotica Pharmaceuticals' current short interest. What is a good short interest ratio for Osmotica Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OSMT shares currently have a short interest ratio of 1.0. Learn More on Osmotica Pharmaceuticals's short interest ratio. What is a good short interest percentage for Osmotica Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.02% of Osmotica Pharmaceuticals' floating shares are currently sold short. Is Osmotica Pharmaceuticals' short interest increasing or decreasing? Osmotica Pharmaceuticals saw a increase in short interest in December. As of December 31st, there was short interest totaling 412,200 shares, an increase of 263.5% from the previous total of 113,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Osmotica Pharmaceuticals' float size? Osmotica Pharmaceuticals currently has issued a total of 62,585,000 shares. Some of Osmotica Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Osmotica Pharmaceuticals currently has a public float of 40,400,000 shares. How does Osmotica Pharmaceuticals' short interest compare to its competitors? 1.02% of Osmotica Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Osmotica Pharmaceuticals: Aerovate Therapeutics, Inc. (21.72%), PyroGenesis Canada Inc. (0.16%), Actinium Pharmaceuticals, Inc. (2.68%), Aadi Bioscience, Inc. (6.58%), Eagle Pharmaceuticals, Inc. (0.46%), NanoViricides, Inc. (0.57%), AEON Biopharma, Inc. (3.71%), Matinas Biopharma Holdings, Inc. (1.05%), Spruce Biosciences, Inc. (0.22%), China Pharma Holdings, Inc. (0.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($9.39 billion), Advanced Micro Devices, Inc. ($9.08 billion), Charter Communications, Inc. ($7.16 billion), Palo Alto Networks, Inc. ($4.05 billion), Lucid Group, Inc. ($3.43 billion), Wayfair Inc. ($3.11 billion), Rivian Automotive, Inc. ($3.05 billion), Datadog, Inc. ($2.76 billion), Zscaler, Inc. ($2.55 billion), and Etsy, Inc. ($1.99 billion). View all of the most shorted stocks. What does it mean to sell short Osmotica Pharmaceuticals stock? Short selling OSMT is an investing strategy that aims to generate trading profit from Osmotica Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Osmotica Pharmaceuticals? A short squeeze for Osmotica Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OSMT, which in turn drives the price of the stock up even further. How often is Osmotica Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OSMT, twice per month. The most recent reporting period available is December, 31 2021. More Short Interest Resources from MarketBeat Related Companies Aerovate Therapeutics Short Interest PyroGenesis Canada Short Interest Actinium Pharmaceuticals Short Interest Aadi Bioscience Short Interest Eagle Pharmaceuticals Short Interest NanoViricides Short Interest AEON Biopharma Short Interest Matinas Biopharma Short Interest Spruce Biosciences Short Interest China Pharma Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OSMT) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Osmotica Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Osmotica Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.